We report an efficient HPLC method for simultaneous qualitative
and quantitative analysis of lincosamide antibiotic injectable formulations
containing Clindamycin phosphate (CMN), benzyl alcohol (BA), and ethylenediaminetetraacetic
acid (EDTA) as major ingredients. The three components were separated
by Phenomenex prodigy C8 (250 mm × 4.6 mm, 5 μm) HPLC column,
flow rate 1.1 mL/min, injection volume 30 μL, and column temperature
35 °C, using 0.05 M sodium acetate buffer (pH 4.5) with acetonitrile
(ACN) in the ratio of 80:20 (v/v). The detection wavelength was set
as 240 nm. The method was validated as per International Conference
on Harmonization (ICH) guidelines and was confirmed to be specific,
precise, accurate, and linear. Method robustness was executed by utilizing
quality in the design of the experiment. Accuracy results were found
to be 99.3–100.5% for CMN, 99.3–100.8% for BA, and 99.1–100.3%
for EDTA. Precision results were obtained as % relative standard deviation
(RSD): 0.6% for CMN, 0.4% for BA, and 0.4% for EDTA. Correlation coefficient
(
r
2
) values were obtained as >0.999
for
the three components. Analytical solutions are stable for 48 h at
benchtop and refrigerator conditions. The greenness of the analytical
method was evaluated by the Green Analytical Procedure Index (GAPI),
National Environmental Method Index (NEMI), analytical eco-scale,
and Analytical Greenness (AGREE) tools to confirm that the method
is eco-friendly.